aluates Reports

$ 0.0

Automative

Global Dual Orexin Receptor Antagonist Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-17W18075

Global Dual Orexin Receptor Antagonist Market Research Report 2024

BUY CHAPTERS

Global Dual Orexin Receptor Antagonist Market Research Report 2025

Code: QYRE-Auto-17W18075

Report

April 2025

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Eisal

Idorsia Ltd

Dual Orexin Receptor Antagonist Market Size

The global market for Dual Orexin Receptor Antagonist was valued at US$ 671 million in the year 2024 and is projected to reach a revised size of US$ 1235 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Dual Orexin Receptor Antagonist Market

A Dual Orexin Receptor Antagonist(DORA)refers to a class of drugs that target both subtypes of orexin receptors,namely orexin receptor type 1(OX1R)and orexin receptor type 2(OX2R).DORAs are primarily developed as treatments for sleep disorders,particularly insomnia.

Currently, the market for Dual Orexin Receptor Antagonists is experiencing gradual acceptance. Pharmaceutical research institutions and clinical experts are increasingly focused on this class of drugs due to their unique mechanism of action and safety advantages in addressing sleep disturbances. At this stage, a diversified market environment is emerging, with both new entrants and approved products contributing to an atmosphere of innovation and evolving treatment concepts.

Future development trends are mainly reflected in advancements in drug design and the expansion of indications. As understanding of the underlying physiology of sleep disorders deepens, research teams are working on optimizing molecular structures to enhance both efficacy and safety. Moreover, there is potential for these agents to be applied beyond traditional insomnia treatment, possibly extending into the management of other neuropsychiatric conditions and fostering the development of personalized therapeutic strategies.

The driving forces behind market growth include the urgent demand for safe and effective treatment options, as well as continuous progress in scientific research and innovative drug development. At the same time, challenges such as stringent regulatory requirements, uncertainties in clinical data, and competition from other similar therapeutic agents pose obstacles. These forces and challenges together shape the current and future market landscape, necessitating a balanced approach between innovation and risk management.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dual Orexin Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Orexin Receptor Antagonist.

The Dual Orexin Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dual Orexin Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dual Orexin Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dual Orexin Receptor Antagonist Market Report

Report Metric	Details
Report Name	Dual Orexin Receptor Antagonist Market
Accounted market size in year	US$ 671 million
Forecasted market size in 2031	US$ 1235 million
CAGR	7.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Suvorexant Lemborexant Daridorexant
Segment by Application	Hospital and Clinic Retail Pharmacies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Eisal, Idorsia
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dual Orexin Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dual Orexin Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dual Orexin Receptor Antagonist Market growing?

Ans: The Dual Orexin Receptor Antagonist Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Dual Orexin Receptor Antagonist Market size in 2031?

Ans: The Dual Orexin Receptor Antagonist Market size in 2031 will be US$ 1235 million.

Who are the main players in the Dual Orexin Receptor Antagonist Market report?

Ans: The main players in the Dual Orexin Receptor Antagonist Market are Merck, Eisal, Idorsia

What are the Application segmentation covered in the Dual Orexin Receptor Antagonist Market report?

Ans: The Applications covered in the Dual Orexin Receptor Antagonist Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Dual Orexin Receptor Antagonist Market report?

Ans: The Types covered in the Dual Orexin Receptor Antagonist Market report are Suvorexant, Lemborexant, Daridorexant

Recommended Reports

Sleep & Insomnia Treatment

Sleep Apnea Devices

Receptor Antagonist Drugs

1 Dual Orexin Receptor Antagonist Market Overview

1.1 Product Definition

1.2 Dual Orexin Receptor Antagonist by Type

1.2.1 Global Dual Orexin Receptor Antagonist Market Value Comparison by Type (2024 VS 2031)

1.2.2 Suvorexant

1.2.3 Lemborexant

1.2.4 Daridorexant

1.3 Dual Orexin Receptor Antagonist by Application

1.3.1 Global Dual Orexin Receptor Antagonist Market Value by Application (2024 VS 2031)

1.3.2 Hospital and Clinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Global Dual Orexin Receptor Antagonist Market Size Estimates and Forecasts

1.4.1 Global Dual Orexin Receptor Antagonist Revenue 2020-2031

1.4.2 Global Dual Orexin Receptor Antagonist Sales 2020-2031

1.4.3 Global Dual Orexin Receptor Antagonist Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Dual Orexin Receptor Antagonist Market Competition by Manufacturers

2.1 Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)

2.2 Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Dual Orexin Receptor Antagonist Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Type & Application

2.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry

2.8 Global Dual Orexin Receptor Antagonist Market Competitive Situation and Trends

2.8.1 Global Dual Orexin Receptor Antagonist Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Dual Orexin Receptor Antagonist Players Market Share by Revenue

2.8.3 Global Dual Orexin Receptor Antagonist Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Dual Orexin Receptor Antagonist Market Scenario by Region

3.1 Global Dual Orexin Receptor Antagonist Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Dual Orexin Receptor Antagonist Sales by Region: 2020-2031

3.2.1 Global Dual Orexin Receptor Antagonist Sales by Region: 2020-2025

3.2.2 Global Dual Orexin Receptor Antagonist Sales by Region: 2026-2031

3.3 Global Dual Orexin Receptor Antagonist Revenue by Region: 2020-2031

3.3.1 Global Dual Orexin Receptor Antagonist Revenue by Region: 2020-2025

3.3.2 Global Dual Orexin Receptor Antagonist Revenue by Region: 2026-2031

3.4 North America Dual Orexin Receptor Antagonist Market Facts & Figures by Country

3.4.1 North America Dual Orexin Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Dual Orexin Receptor Antagonist Sales by Country (2020-2031)

3.4.3 North America Dual Orexin Receptor Antagonist Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Dual Orexin Receptor Antagonist Market Facts & Figures by Country

3.5.1 Europe Dual Orexin Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Dual Orexin Receptor Antagonist Sales by Country (2020-2031)

3.5.3 Europe Dual Orexin Receptor Antagonist Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dual Orexin Receptor Antagonist Market Facts & Figures by Region

3.6.1 Asia Pacific Dual Orexin Receptor Antagonist Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Dual Orexin Receptor Antagonist Sales by Region (2020-2031)

3.6.3 Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Dual Orexin Receptor Antagonist Market Facts & Figures by Country

3.7.1 Latin America Dual Orexin Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Dual Orexin Receptor Antagonist Sales by Country (2020-2031)

3.7.3 Latin America Dual Orexin Receptor Antagonist Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Dual Orexin Receptor Antagonist Market Facts & Figures by Country

3.8.1 Middle East and Africa Dual Orexin Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Dual Orexin Receptor Antagonist Sales by Country (2020-2031)

3.8.3 Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dual Orexin Receptor Antagonist Sales by Type (2020-2031)

4.1.1 Global Dual Orexin Receptor Antagonist Sales by Type (2020-2025)

4.1.2 Global Dual Orexin Receptor Antagonist Sales by Type (2026-2031)

4.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031)

4.2 Global Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)

4.2.1 Global Dual Orexin Receptor Antagonist Revenue by Type (2020-2025)

4.2.2 Global Dual Orexin Receptor Antagonist Revenue by Type (2026-2031)

4.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031)

4.3 Global Dual Orexin Receptor Antagonist Price by Type (2020-2031)

5 Segment by Application

5.1 Global Dual Orexin Receptor Antagonist Sales by Application (2020-2031)

5.1.1 Global Dual Orexin Receptor Antagonist Sales by Application (2020-2025)

5.1.2 Global Dual Orexin Receptor Antagonist Sales by Application (2026-2031)

5.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)

5.2 Global Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

5.2.1 Global Dual Orexin Receptor Antagonist Revenue by Application (2020-2025)

5.2.2 Global Dual Orexin Receptor Antagonist Revenue by Application (2026-2031)

5.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)

5.3 Global Dual Orexin Receptor Antagonist Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Dual Orexin Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Dual Orexin Receptor Antagonist Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Eisal

6.2.1 Eisal Company Information

6.2.2 Eisal Description and Business Overview

6.2.3 Eisal Dual Orexin Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Eisal Dual Orexin Receptor Antagonist Product Portfolio

6.2.5 Eisal Recent Developments/Updates

6.3 Idorsia

6.3.1 Idorsia Company Information

6.3.2 Idorsia Description and Business Overview

6.3.3 Idorsia Dual Orexin Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Idorsia Dual Orexin Receptor Antagonist Product Portfolio

6.3.5 Idorsia Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dual Orexin Receptor Antagonist Industry Chain Analysis

7.2 Dual Orexin Receptor Antagonist Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dual Orexin Receptor Antagonist Production Mode & Process Analysis

7.4 Dual Orexin Receptor Antagonist Sales and Marketing

7.4.1 Dual Orexin Receptor Antagonist Sales Channels

7.4.2 Dual Orexin Receptor Antagonist Distributors

7.5 Dual Orexin Receptor Antagonist Customer Analysis

8 Dual Orexin Receptor Antagonist Market Dynamics

8.1 Dual Orexin Receptor Antagonist Industry Trends

8.2 Dual Orexin Receptor Antagonist Market Drivers

8.3 Dual Orexin Receptor Antagonist Market Challenges

8.4 Dual Orexin Receptor Antagonist Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Eisal

Idorsia Ltd

List of Tables

Table 1. Global Dual Orexin Receptor Antagonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Dual Orexin Receptor Antagonist Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Dual Orexin Receptor Antagonist Market Competitive Situation by Manufacturers in 2024

Table 4. Global Dual Orexin Receptor Antagonist Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Dual Orexin Receptor Antagonist Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Dual Orexin Receptor Antagonist Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Type & Application

Table 12. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dual Orexin Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual Orexin Receptor Antagonist as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dual Orexin Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Dual Orexin Receptor Antagonist Sales by Region (2020-2025) & (K Units)

Table 18. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2025)

Table 19. Global Dual Orexin Receptor Antagonist Sales by Region (2026-2031) & (K Units)

Table 20. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2026-2031)

Table 21. Global Dual Orexin Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2025)

Table 23. Global Dual Orexin Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2026-2031)

Table 25. North America Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Dual Orexin Receptor Antagonist Sales by Country (2020-2025) & (K Units)

Table 27. North America Dual Orexin Receptor Antagonist Sales by Country (2026-2031) & (K Units)

Table 28. North America Dual Orexin Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Dual Orexin Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Dual Orexin Receptor Antagonist Sales by Country (2020-2025) & (K Units)

Table 32. Europe Dual Orexin Receptor Antagonist Sales by Country (2026-2031) & (K Units)

Table 33. Europe Dual Orexin Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Dual Orexin Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Dual Orexin Receptor Antagonist Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Dual Orexin Receptor Antagonist Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Dual Orexin Receptor Antagonist Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Dual Orexin Receptor Antagonist Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Dual Orexin Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Dual Orexin Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Dual Orexin Receptor Antagonist Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Dual Orexin Receptor Antagonist Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Dual Orexin Receptor Antagonist Sales (K Units) by Type (2020-2025)

Table 51. Global Dual Orexin Receptor Antagonist Sales (K Units) by Type (2026-2031)

Table 52. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2025)

Table 53. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2026-2031)

Table 54. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2025)

Table 57. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2026-2031)

Table 58. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Type (2020-2025)

Table 59. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Type (2026-2031)

Table 60. Global Dual Orexin Receptor Antagonist Sales (K Units) by Application (2020-2025)

Table 61. Global Dual Orexin Receptor Antagonist Sales (K Units) by Application (2026-2031)

Table 62. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2025)

Table 63. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2026-2031)

Table 64. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2025)

Table 67. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2026-2031)

Table 68. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Application (2020-2025)

Table 69. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck Dual Orexin Receptor Antagonist Product

Table 74. Merck Recent Developments/Updates

Table 75. Eisal Company Information

Table 76. Eisal Description and Business Overview

Table 77. Eisal Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Eisal Dual Orexin Receptor Antagonist Product

Table 79. Eisal Recent Developments/Updates

Table 80. Idorsia Company Information

Table 81. Idorsia Description and Business Overview

Table 82. Idorsia Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Idorsia Dual Orexin Receptor Antagonist Product

Table 84. Idorsia Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Dual Orexin Receptor Antagonist Distributors List

Table 88. Dual Orexin Receptor Antagonist Customers List

Table 89. Dual Orexin Receptor Antagonist Market Trends

Table 90. Dual Orexin Receptor Antagonist Market Drivers

Table 91. Dual Orexin Receptor Antagonist Market Challenges

Table 92. Dual Orexin Receptor Antagonist Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Dual Orexin Receptor Antagonist

Figure 2. Global Dual Orexin Receptor Antagonist Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dual Orexin Receptor Antagonist Market Share by Type: 2024 & 2031

Figure 4. Suvorexant Product Picture

Figure 5. Lemborexant Product Picture

Figure 6. Daridorexant Product Picture

Figure 7. Global Dual Orexin Receptor Antagonist Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Dual Orexin Receptor Antagonist Market Share by Application: 2024 & 2031

Figure 9. Hospital and Clinic

Figure 10. Retail Pharmacies

Figure 11. Other

Figure 12. Global Dual Orexin Receptor Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Dual Orexin Receptor Antagonist Market Size (2020-2031) & (US$ Million)

Figure 14. Global Dual Orexin Receptor Antagonist Sales (2020-2031) & (K Units)

Figure 15. Global Dual Orexin Receptor Antagonist Average Price (US$/Unit) & (2020-2031)

Figure 16. Dual Orexin Receptor Antagonist Report Years Considered

Figure 17. Dual Orexin Receptor Antagonist Sales Share by Manufacturers in 2024

Figure 18. Global Dual Orexin Receptor Antagonist Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Dual Orexin Receptor Antagonist Players: Market Share by Revenue in Dual Orexin Receptor Antagonist in 2024

Figure 20. Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Dual Orexin Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Dual Orexin Receptor Antagonist Sales Market Share by Country (2020-2031)

Figure 23. North America Dual Orexin Receptor Antagonist Revenue Market Share by Country (2020-2031)

Figure 24. United States Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Dual Orexin Receptor Antagonist Sales Market Share by Country (2020-2031)

Figure 27. Europe Dual Orexin Receptor Antagonist Revenue Market Share by Country (2020-2031)

Figure 28. Germany Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2031)

Figure 35. China Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Dual Orexin Receptor Antagonist Sales Market Share by Country (2020-2031)

Figure 43. Latin America Dual Orexin Receptor Antagonist Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Dual Orexin Receptor Antagonist Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Dual Orexin Receptor Antagonist Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Dual Orexin Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Dual Orexin Receptor Antagonist by Type (2020-2031)

Figure 54. Global Revenue Market Share of Dual Orexin Receptor Antagonist by Type (2020-2031)

Figure 55. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Dual Orexin Receptor Antagonist by Application (2020-2031)

Figure 57. Global Revenue Market Share of Dual Orexin Receptor Antagonist by Application (2020-2031)

Figure 58. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Application (2020-2031)

Figure 59. Dual Orexin Receptor Antagonist Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Androgen Receptor AR Antagonist Market Research Report 2024

Global Long acting Melatonin Receptor Agonists Market Research Report 2025

Global AT1 Receptor Antagonists Market Research Report 2024

Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024

Global Dopamine Receptor Agonists Market Research Report 2025

Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1 Receptor Antagonist Market Research Report 2024

Global Neurokinin Receptor Antagonists Market Research Report 2024

Global Suvorexant API Market Research Report 2024

Global Dopamine Receptor Agonists For PD Market Research Report 2025

Global IL 23 Receptor Antagonist Market Research Report 2024

Global Amlodipine and Olmesartan Market Insights Forecast to 2030

Global GnRH Receptor Antagonists Market Research Report 2024

Global Valsartan Capsules Market Research Report 2024

Global NK 1 Receptor Antagonists Market Research Report 2024

Global Vitamin D Receptor VDR or Calcitriol Receptor Agonist Market Research Report 2024

Global Melanocortin Receptor Agonist Drugs Market Research Report 2024

Global Azilsartan Medoxomil API Market Research Report 2025

Global Bradykinin Receptor Antagonists Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions